PD-1-M1-NK cells for advanced stomach or colorectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new cell therapy using special immune cells (PD-1-M1-NK cells) that are designed to attack cancer cells. It is for people with advanced stomach or colorectal cancer that has not responded to at least two prior treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have advanced stomach or colorectal cancer that has progressed after at least two standard treatments.
- Your tumor tests positive for a protein called PD-L1.
- You have at least one measurable tumor (by imaging).
- You are generally in good health (able to care for yourself, no serious organ problems).
- You have no uncontrolled infections or brain metastases, and you have not had cell therapy before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies an experimental cell therapy called NK510 for people with advanced stomach or colorectal cancer that has not responded to standard treatments. The therapy uses natural killer cells, a type of immune cell, to attack the cancer. It may help slow or stop the cancer's growth.
This trial tests a new therapy where immune cells (TILs) from your tumor are modified to fight cancer more effectively. It's for people with advanced colorectal cancer who can't get standard treatments.
This trial tests specially engineered immune cells (CAR-NK cells) designed to find and attack pancreatic cancer cells. The cells target specific proteins on cancer cells and may help people whose cancer has progressed despite prior treatment.
This trial tests a new type of immune cell therapy called CAR-NK cells that target two proteins (MSLN and MUC1) often found on pancreatic cancer cells. It is for people whose cancer has spread or cannot be removed, and who have already tried at least one standard treatment.
This trial tests adding natural killer (NK) cells to your usual maintenance treatment for advanced solid tumors. NK cells are a type of immune cell that may help your body fight cancer more effectively and delay the cancer from growing.
This trial tests a new treatment using natural killer (NK) cells, a type of immune cell, to fight advanced solid tumors. It may be an option if standard treatments have stopped working or are not available.
Hear when a new Advanced Gastric or Colorectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.